Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y007322 | — |
No additional AEs/PQC reported; Caller reports GARDASIL 9 PFS leaked during administration and patient did not receive full dose.; GARDASIL 9 PFS leaked during administration and patient did not receive full dose.; Caller reports GARDASIL 9 PFS leaked during administration and patient did not receive full dose.; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-FEB-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (valid lot number Y007322, expiration date: 18-AUG-2026) intramuscular injection for prophylaxis (dose, dose number, anatomical location, route of administration was not provided) and was leaked during administration and patient did not receive full dose ( product leakage, poor quality device used, accidental underdose). No other information provided. No additional adverse event (AE) reported.